Prabhakar Sudesh, Saraf Manish Kumar, Banik Avijit, Anand Akshay
Neuroscience Research Lab, Department of Neurology, Post Graduate Institute of Medical Education and Research, Sector-12 Chandigarh, 160012, INDIA.
Ann Neurosci. 2011 Jan;18(1):8-13. doi: 10.5214/ans.0972.7531.1118104.
Amnesia is characterized by loss of memory that could result from abnormal neuro-chemical homeostasis, genetic predisposition or drug abuse. We earlier reported that B. monniera attenuates diazepam, scopolamine and L-NNA induced amnesia and wanted to test if SOD levels were affected by its administration.
B. monniera is earlier reported to augment the defense system for oxidative stress by increasing the activities of superoxide dismutase, therefore, we investigated its levels after B. monniera administration in combination with different amnesic agents.
We treated mice with amnesic agents such as scopolamine, diazepam, L-NNA and MK 801 either with or without B. monniera.
Diazepam (1.75 mg/kg ip) significantly reduced SOD activity while it was unaltered when Scopolamine (0.1 mg/kg ip), MK 801 (0.17 mg/kg ip) and L-NNA (30 mg/kg ip) were administered. B. monniera significantly attenuated diazepam induced suppression of SOD activity.
It is suggested that the mechanism of B. monniera's antiamnesic effect may vary depending on the type of amnesic agent used. However, antioxidant mechanism may be central to evoking the memory enhancing effects of B. monniera against diazepam induced amnesia.
失忆症的特征是记忆丧失,这可能由异常的神经化学稳态、遗传易感性或药物滥用引起。我们之前报道过,印度人参可减轻地西泮、东莨菪碱和L-硝基精氨酸甲酯诱导的失忆症,并想测试其给药是否会影响超氧化物歧化酶(SOD)水平。
之前有报道称印度人参通过提高超氧化物歧化酶的活性来增强氧化应激防御系统,因此,我们研究了在与不同失忆剂联合使用印度人参后其水平的变化。
我们用东莨菪碱、地西泮、L-硝基精氨酸甲酯和MK-801等失忆剂处理小鼠,处理时有的使用印度人参,有的不使用。
地西泮(腹腔注射1.75毫克/千克)显著降低了SOD活性,而腹腔注射东莨菪碱(0.1毫克/千克)、MK-801(0.17毫克/千克)和L-硝基精氨酸甲酯(30毫克/千克)时SOD活性未发生改变。印度人参显著减轻了地西泮诱导的SOD活性抑制。
提示印度人参抗失忆作用的机制可能因所用失忆剂的类型而异。然而,抗氧化机制可能是印度人参发挥对抗地西泮诱导失忆的记忆增强作用的核心机制。